Jared Holz, Mizuho Healthcare Sector strategist, joins 'Closing Bell Overtime' to talk Moderna and Novo Nordisk.

Robert F. Kennedy Jr. petitioned the F.D.A. to revoke authorization of the shots at a time when they were in high demand and ...

Plus: Blue Origin and SpaceX launch big rockets, how magnets could guide lasers to make better computers, how to best work ...

Beyond sidestepping people’s fear of needles, these vaccines would also make it easier to store and distribute ahead of ...

The VDH and Scott are advocating for people to get their vaccinations before winter. Scott said he has received his COVID ...

Moderna slashed its 2025 revenue projection by $1bn on Monday, citing reduced demand for its Covid-19 and respiratory ...

The VDH and Scott are advocating for people to get their vaccinations before winter. Scott said he has received his COVID ...

Stock-plunging mRNA vaccine maker, already in bed with feds on vaccine royalties, says booster not "causally" related without ...

The intervening years have both sped and crawled by, too busy at times to take stock of all that has changed, too plodding to ...

Elasomeran + imelasomeran is under clinical development by Moderna and currently in Phase III for Coronavirus Disease 2019 (COVID-19).

MRNA-1273.213 is under clinical development by Moderna and currently in Phase III for Coronavirus Disease 2019 (COVID-19).